医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

LiveLeaf Licenses Technology to InQpharm Group for Its Animal Health Division

2016年04月04日 PM10:00
このエントリーをはてなブックマークに追加


 

SAN CARLOS, Calif. & KUALA LUMPUR, Malaysia

In a strategic move to further strengthen its Animal Health portfolio of unique natural technologies, InQpharm Group has acquired a license for one of the world’s most significant recent developments in that field, phytobiologics developed by LiveLeaf, Inc. The license for production livestock and equine use initially extends rights for Europe and portions of Asia Pacific, with InQpharm having an option on other significant territories.

Branded LiveXtract® in its native US market, this patented technology contains two highly bioactive botanical complexes with a very well documented history of safe use. LiveXtract® improves the gastrointestinal health of young food-producing animals and helps to keep them on the optimal natural growth curve. Academic studies and extensive experience from field trials have already demonstrated the highly significant benefit of this technology as part of an antibiotic-free program.

InQpharm’s existing Vetrinol™, Vetrinol™ Plus and Vetrinol™ Neo product lines have already been successfully introduced in Europe for the prevention and treatment of reducing somatic cell count, sub-clinical mastitis and calf diarrhea. This latest acquisition will give InQpharm critical mass as a leader in the field of bioactive natural alternatives for the animal health industry.

“We are excited to add this breakthrough nature-based technology to our already successful and highly diverse group of innovative offerings. This agreement is evidence of our continued commitment to seek out novel solutions to the challenges of sustainable food production,” said Thomas Hafner, founder and CEO of Zaluvida, InQpharm’s parent company. “These products are perfectly aligned with our focus on natural alternatives to reduce antimicrobial overuse in growth promotion,” he added.

Commenting on the deal, Alex Huang, founder and CEO of LiveLeaf said, “We are delighted to have found a like-minded partner to extend our reach in deploying this important breakthrough worldwide. Our LiveXtract phytobiologics provide production farmed animals the powerful immune benefits of a natural field grazing diet, but through a practical controlled delivery. InQpharm further validates the potential of our technology to help meet the world’s growing demand for protein without compromising the health of future generations.”

About InQpharm

InQpharm is a global life science company that develops best-in-class and first-in-class healthcare solutions based on proprietary bioactive platform technologies. Already a true game-changer and market leader in several consumer health categories, InQpharm’s innovative solutions nourish, protect and improve the lives of global consumers and animals alike.

Founded and headquartered in Kuala Lumpur, Malaysia, the company has offices in Germany, The Netherlands, United Kingdom and in the United States with Switzerland to open by mid-year. These InQpharm facilities around the globe provide an end-to-end ecosystem of centres of excellence – from molecule and compound discovery to delivering ground breaking products to the end consumer. InQpharm is fully owned by the Singaporean Life Science investment firm Zaluvida Holdings.

For more information, please visit inqpharm.com and zaluvida.com

About LiveLeaf

LiveLeaf, Inc. is a Silicon Valley company applying modern immunology concepts and clinical research to ancient medicinal knowledge in pioneering development of phytobiologics, a novel ingredient paradigm harnessing the biochemistry of living plant immunity on a commercial scale. Since 2008, LiveLeaf has been advancing this technology platform and developed a deep pipeline of wellness and therapeutic applications. The company’s extensive portfolio of patents and products are made available for license to partners committed to a more sustainable health future for humanity.

LiveXtract phytobiologics deliver an unprecedented combination of immediate benefit and intrinsic safety that has been validated through laboratory testing, human clinical studies, retail consumer products, and over a million farm animals. LiveXtract is the active ingredient in natural digestive care products sold in the US under the LiveLeaf brand and to the agricultural industry through Grazix Animal Health, Inc., a subsidiary of LiveLeaf. These demonstrate extraordinarily efficient restoration of healthy gut function against a wide range of challenges. The company’s phytobiologics have also demonstrated compelling benefits in a wide range of topical applications.

Please visit liveleaf.com and grazix.com to learn more.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160404005333/en/

CONTACT

LiveLeaf, Inc.
Alex Huang, +1 650-274-3888
ahuang@liveleaf.com
or
InQpharm
Group Sdn. Bhd.

Marcel Willemsen, +49 6743 947148
mwillemsen@inqpharm.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三井化学开发全球首款灵活的高强度柔性无纺布AIRYFA™
  • APR应用制药研究公司参加第9届ChinaBio®合作论坛:依托瑞士创新产品和科学技术深耕中国市场
  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定